This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Johns Hopkins University, University of Pennsylvania, Nationwide Children's Hospital. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Baltimore, MD (US) (2013)
- Dallas, TX (US) (2014 - 2016)
Company Filing History:



Years Active: 2013-2016
Title: Innovations and Contributions of Joshua T Mendell
Introduction
Joshua T Mendell is a prominent inventor based in Dallas, TX (US). He has made significant contributions to the field of biomedical research, particularly in the area of angiogenesis and hepatic neoplasia. With a total of three patents to his name, Mendell's work has the potential to impact medical treatments and therapies.
Latest Patents
Mendell's latest patents include "Compositions and methods for modulating angiogenesis," which features compositions and methods that are useful for modulating angiogenesis. Another notable patent is "Compositions and methods for treating hepatic neoplasia," which provides compositions and methods featuring miR-26 microRNA polynucleotides for the diagnosis, treatment, or prevention of hepatic neoplasia. These innovations highlight his focus on addressing critical health issues.
Career Highlights
Throughout his career, Mendell has worked with esteemed institutions such as The Johns Hopkins University and the University of Pennsylvania. His experience in these prestigious organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Mendell has collaborated with notable colleagues, including Erik A Wentzel and Andrei Thomas-Tikhonenko. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Joshua T Mendell's contributions to the field of biomedical research through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments and therapies that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile